T-cell non-Hodgkin lymphoma Epstein-Barr virus-associated lymphoproliferative disorder post-transplant lymphoproliferative disease https://github.com/monarch-initiative/mondo/issues/9097 https://rarediseases.info.nih.gov/diseases/9553/post-transplant-lymphoproliferative-disease https://www.malacards.org/card/post_transplant_lymphoproliferative_disease UMLS:C0432487 ICDO:9971/1 MEDGEN:98160 GARD:0009553 Orphanet:70568 NCIT:C4727 MONDO:0019088 Post-transplant lymphoproliferative disorder (PTLD) is a polyclonal (benign) or clonal (malignant) proliferation of lymphoid cells that develops as a consequence of immunosuppression in a recipient of a solid organ or bone marrow allograft. PTLDs comprise a spectrum ranging from early, Epstein-Barr virus (EBV)-driven polyclonal lymphoid proliferations to EBV-positive or EBV- negative lymphomas of predominantly B-cell or less often T-cell type. (WHO, 2001) NORD:1950 MedDRA:10051358 PTLD ICD10CM:D47.Z1 post-transplant lymphoproliferative disorder SCTID:254290004 immunodeficiency-associated lymphoproliferative disease disease related to transplantation